Compliance & Ethics
Bristol-Myers Squibb conducts business with, and maintains a culture of, ethics and integrity across our worldwide organization. We require all our employees, in addition to contractors, consultants, vendors and individuals who do business with Bristol-Myers Squibb, to know and adhere to our high standards of ethics and integrity.
In our mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases, we support a clean and healthy environment and subscribe to policies and practices that merit the trust and confidence of our society.
Each of our employees is required to complete training on our Standards of Business Conduct and Ethics
biannually, and to certify that they have read, understand, will comply with, and are not aware of any violations of the Standards. Timely completion of this training is a condition of employment. Our Standards address a broad range of topics relating to ethics and global business practices.
Bristol-Myers Squibb recognizes that Third Parties have an important role in its success. We strive to conduct business only with Third Parties who share our commitment to the Standards of Business Conduct and Ethics for Third Parties (3P Standards)
. We encourage Third Parties to adopt and apply the 3P Standards, and to have processes and/or systems in place to support operating in compliance with all applicable laws, regulations, guidelines and industry codes. Specific requirements for adherence to the 3P Standards are included in contracts with third parties.
Our Standards of Business Conduct and Ethics (PDF: 9 MB)
Our Standards of Business Conduct and Ethics for Third Parties
Our Compliance and Ethics Code of Conduct for U.S. Pharmaceuticals
(PDF: 219 KB)
Our Annual Declaration of Compliance for the State of California
(PDF: 102 KB)
Our Description for the State of California of the Bristol-Myers Squibb Comprehensive Compliance Program (PDF: 111 KB)
Our Sharps Management Plan (PDF: 579 KB)
(Bristol-Myers Squibb Company and Amylin Pharmaceuticals, LLC Sharps Management Plan for the Continental United States, Alaska and Hawaii)
Our California Transparency in Supply Chains Act Disclosure (PDF: 53 KB)